Search

Your search keyword '"Hausdorff WP"' showing total 106 results

Search Constraints

Start Over You searched for: Author "Hausdorff WP" Remove constraint Author: "Hausdorff WP"
106 results on '"Hausdorff WP"'

Search Results

1. The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers.

2. Multinational study of pneumococcal serotypes causing acute otitis media in children

4. Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

5. Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease.

6. Pediatric Parapneumonic Empyema, Spain

7. Global Meningococcal Initiative: Insights on antibiotic resistance, control strategies and advocacy efforts in Western Europe.

8. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development.

9. The role of vaccines in reducing antimicrobial resistance: A review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens.

10. Facilitating the development of urgently required combination vaccines.

11. Lassa fever vaccine use cases and demand: Perspectives from select West African experts.

12. Reassessing potential economic value and health impact of effective Shigella vaccines.

13. Vaccine value profile for enterotoxigenic Escherichia coli (ETEC).

14. Vaccine value profile for Shigella.

15. Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low- and middle-income settings.

16. Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study.

17. Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study.

18. Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening.

19. Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study.

20. The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers.

21. Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries.

22. What Drives the Value of a Shigella Vaccine?

23. National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study.

24. Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines.

25. Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis.

26. Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.

28. Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.

29. High levels of inherent variability in microbiological assessment of bronchoalveolar lavage samples from children with persistent bacterial bronchitis and healthy controls.

30. Effect of vaccination on the use of antimicrobial agents: a systematic literature review.

33. The choice of analytical methodology can alter conclusions regarding herd effects of paediatric pneumococcal vaccination programmes.

34. Testing Pneumonia Vaccines in the Elderly: Determining a Case Definition for Pneumococcal Pneumonia in the Absence of a Gold Standard.

35. lytA Quantitative PCR on Sputum and Nasopharyngeal Swab Samples for Detection of Pneumococcal Pneumonia among the Elderly.

36. What is the heterogeneity in the impact seen with pneumococcal conjugate vaccines telling us?

37. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.

38. Etiology of Acute Otitis Media in Children Less Than 5 Years of Age: A Pooled Analysis of 10 Similarly Designed Observational Studies.

39. Healthcare-seeking behaviour of primary caregivers for acute otitis media in children aged 6 months to <30 months in Panama: results of a cross-sectional survey.

40. Epidemiology of invasive pneumococcal disease in Saudi Arabian children younger than 5years of age.

41. Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program.

42. Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement.

43. Correction: Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial.

44. Effect of antimicrobial use on pneumococcal diagnostic tests in elderly patients with community-acquired pneumonia.

45. Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough.

46. Haemophilus influenzae type b as an important cause of culture-positive acute otitis media in young children in Thailand: a tympanocentesis-based, multi-center, cross-sectional study.

47. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.

49. Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study.

50. Bacterial etiology of empyema thoracis and parapneumonic pleural effusion in Thai children aged less than 16 years.

Catalog

Books, media, physical & digital resources